ANTI B4 BLOCKED RICIN IN B LINEAGE ALL/HIGH DOSE CYTARABIN IN NON B LINEAGE ALL

Project: Research project

Project Details

Description

This NCI-sponsored cooperative group (CALGB) protocol seeks to determine the role of a consolidation therapy for acute lymphoblastic leukemia (ALL) in which an antibody-based therapy (anti B4-blocked ricin) is used for B-lineage ALL while a high dose chemotherapy regimen (cytarabine) is used for non-B-cell lineage ALL. The protocol is ongoing and it is too early to comment.
StatusFinished
Effective start/end date10/1/959/30/96

Funding

  • National Center for Research Resources

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.